Paolo Prandoni

Q: What Schools Are Affiliated With Paolo Prandoni

Paolo Prandoni is affiliated with the following schools: University of Amsterdam, University of Milan, University of Padua, Karolinska Institute

Paolo Prandoni's AcademicInfluence.com Rankings

Paolo Prandoni

Engineering

#2861

World Rank

#3850

Historical Rank

Applied Physics

#426

World Rank

#443

Historical Rank

Electrical Engineering

#570

World Rank

#628

Historical Rank

engineering Degrees

Download Badge

Engineering

Why Is Paolo Prandoni Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paolo Prandoni's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (5208)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
The Long-Term Clinical Course of Acute Deep Venous Thrombosis (1996) (2040)
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. (2004) (1730)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. (2002) (1681)
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019) (1493)
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020) (1486)
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. (1996) (1112)
Detection of deep-vein thrombosis by real-time B-mode ultrasonography. (1989) (869)
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score (2010) (847)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. (2007) (758)
Accuracy of clinical assessment of deep-vein thrombosis (1995) (738)
Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. (1992) (697)
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer (2013) (636)
An association between atherosclerosis and venous thrombosis. (2003) (625)
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis (1992) (607)
The effect of low molecular weight heparin on survival in patients with advanced malignancy. (2005) (593)
Aspirin for preventing the recurrence of venous thromboembolism. (2012) (581)
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. (2001) (553)
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. (1997) (528)
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism (2002) (527)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (2017) (521)
Cancer and venous thromboembolism. (1996) (435)
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study (1998) (412)
Definition of post‐thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization (2009) (402)
Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome (2004) (399)
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism (2003) (391)
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). (1997) (391)
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. (2014) (384)
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study (2007) (379)
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. (1997) (354)
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: A randomized, controlled trial (2005) (342)
Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia (1999) (334)
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial (2004) (326)
Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. (1993) (314)
A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis (1993) (304)
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial (2008) (289)
Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. (2011) (282)
Fondaparinux for the treatment of superficial-vein thrombosis in the legs. (2010) (277)
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. (2008) (276)
Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome (2005) (276)
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. (1999) (273)
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer (2012) (271)
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. (2003) (267)
Post‐thrombotic syndrome: prevalence, prognostication and need for progress (2009) (251)
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials. (2014) (248)
Cancer and venous thromboembolism. (2005) (246)
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. (2018) (236)
D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study (1998) (235)
Three months vs. one year of oral anticoagulant therapy for idiopathic deep venous thrombosis (2002) (232)
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. (2009) (231)
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration (2014) (226)
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism (2007) (222)
Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study (2010) (220)
Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis (1996) (217)
Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation (1992) (211)
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. (2005) (208)
Simplification of the diagnostic management of suspected deep vein thrombosis. (2002) (205)
Erratum to: Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention (2011) (200)
ACQUIRED RISK FACTORS AND DEEP VEIN THROMBOSIS IN SYMPTOMATIC OUT PATIENTS (1994) (196)
Prevention and treatment of venous thromboembolism--International Consensus Statement. (2013) (188)
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. (1999) (183)
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. (2007) (182)
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis (2006) (182)
Identification of intermediate-risk patients with acute symptomatic pulmonary embolism (2014) (174)
Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry (2010) (171)
Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. (2016) (170)
Vein abnormalities and the post‐thrombotic syndrome (2005) (170)
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. (2014) (169)
European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. (2020) (168)
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism (2008) (166)
Arterial cardiovascular events, statins, low‐dose aspirin and subsequent risk of venous thromboembolism: a population‐based case‐control study (2009) (166)
Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism (2004) (165)
The metabolic syndrome and the risk of venous thrombosis: a case–control study (2006) (164)
Undiagnosed malignancy in patients with deep vein thrombosis (1998) (163)
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study (2004) (156)
Recurrence of venous thromboembolism in patients with familial thrombophilia. (1997) (152)
A Randomised Trial of Subcutaneous Low Molecular Weight Heparin (CY 216) Compared with lntravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis (1991) (150)
Cancer and venous thromboembolism: an overview. (1999) (149)
Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. (2008) (142)
A prospective study on cardiovascular events after acute pulmonary embolism. (2005) (142)
Deep-vein thrombosis (1999) (142)
Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience (2020) (139)
Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement (1992) (138)
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis (2019) (136)
A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process (1998) (135)
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) (2018) (134)
A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. (1997) (133)
Patients With Cancer (2013) (132)
Hyperhomocysteinemia and Deep-Vein Thrombosis A Case-Control Study (1996) (131)
An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. (1999) (130)
Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). (2006) (127)
Prevention and Treatment of Venous Thromboembolism (2013) (125)
The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis (2002) (123)
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. (2004) (121)
Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. (2005) (121)
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. (2002) (116)
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. (1995) (115)
High vs. low doses of low‐molecular‐weight heparin for the treatment of superficial vein thrombosis of the legs: a double‐blind, randomized trial (2005) (105)
Lower extremity venography with iohexol: results and complications. (1990) (103)
Efficacy and Safety of a Low-Molecular-Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial (1997) (102)
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. (2002) (102)
Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis (2011) (101)
Endothelial dysfunction in patients with spontaneous venous thromboembolism. (2007) (101)
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. (2002) (100)
Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism (2013) (97)
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. (2012) (97)
Sonological models for timbre characterization (1997) (95)
Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopatic deep venous thrombosis. (2001) (95)
Deep Venous Thrombosis and Lupus Anticoagulant (1996) (94)
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow‐up (2009) (91)
Upper extremity deep venous thrombosis. (2006) (91)
High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. (2002) (89)
Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism (2006) (89)
Links between arterial and venous disease (2007) (89)
Upper extremity deep vein thrombosis. (1999) (88)
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism (2017) (88)
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis (2013) (87)
Travel and risk of venous thrombosis (2000) (86)
Venous thromboembolism and atherosclerosis: is there a link? (2007) (85)
Comparison of the Accuracy of Impedance Plethysmography and Compression Ultrasonography in Outpatients with Clinically Suspected Deep Vein Thrombosis (1995) (84)
Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. (1999) (84)
Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study (2001) (84)
Antiphospholipid Antibodies, Recurrent Thromboembolism, and Intensity of Warfarin Anticoagulation (1996) (83)
Antithrombotic Strategies in Patients with Cancer (1997) (81)
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study (2005) (79)
The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: The Padua province experience (2020) (77)
Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients. (1992) (76)
Long-term outcomes after deep venous thrombosis of the lower extremities (1998) (75)
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism (2017) (74)
The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation (2015) (73)
Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. (2015) (73)
Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry (2008) (71)
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation (2003) (71)
The postthrombotic syndrome (2010) (70)
Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population‐based cohort study (2017) (69)
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. (2018) (68)
A prospective study on cardiovascular events after acute pulmonary embolism (2005) (68)
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutationRisk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis (2000) (68)
Venous thromboembolism and cancer: a two-way clinical association. (1997) (67)
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. (2000) (66)
Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. (2012) (65)
Decision analysis for cancer screening in idiopathic venous thromboembolism (2005) (65)
The Risk of Fetal Loss in Family Members of Probands with Factor V Leiden Mutation (1999) (64)
Warfarin versus low-molecular-weight heparin therapy in cancer patients. (2005) (63)
Risk of recurrent venous thromboembolism according to baseline risk factor profiles. (2018) (63)
Venous and arterial thrombosis: Two aspects of the same disease? (2009) (63)
Duration of anticoagulation after venous thromboembolism in real world clinical practice. (2015) (62)
Treatment of venous thromboembolism with rivaroxaban in relation to body weight (2016) (62)
Venous Thromboembolism as First Manifestation of Cancer (2001) (60)
An FIR cascade structure for adaptive linear prediction (1998) (59)
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. (2000) (59)
Comparison of Real-Time B-Mode Ultrasonography and Doppler Ultrasound with Contrast Venography in the Diagnosis of Venous Thrombosis in Symptomatic Outpatients (1993) (58)
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry (2018) (58)
Optimal time segmentation for signal modeling and compression (1997) (58)
Acquired risk factors for venous thromboembolism in medical patients. (2005) (56)
Approximation and compression of piecewise smooth functions (1999) (56)
Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer (1999) (56)
Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome (2005) (56)
Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. (2001) (55)
Cancer, thrombosis and heparin-induced thrombocytopenia. (2007) (55)
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment (2014) (55)
Signal Processing for Communications (2008) (54)
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism (2015) (53)
Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial (2016) (53)
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE (2017) (53)
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE (2017) (53)
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. (2005) (53)
Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. (1995) (52)
Venous and arterial thrombosis: two aspects of the same disease? (2009) (52)
Inherited thrombophilia and venous thromboembolism. (2006) (52)
Does Hemophilia Protect Against Atherosclerosis? A Case-Control Study (2006) (52)
Antithrombotic Drugs in the Primary Medical Management of Intermittent Claudication: A Meta-analysis (1999) (51)
How I treat venous thromboembolism in patients with cancer. (2005) (51)
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis (2016) (50)
Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. (1996) (50)
Superficial vein thrombosis: risk factors, diagnosis, and treatment. (2006) (50)
Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) (2016) (50)
Double vena cava filter insertion in congenital duplicated inferior vena cava: a case report and literature review. (2006) (49)
Screening for occult cancer in patients with idiopathic venous thromboembolism: Yes (2003) (49)
ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. (2013) (48)
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study. (2011) (47)
Diagnosis of deep-vein thrombosis using an objective Doppler method. (1990) (47)
Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis (1991) (45)
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. (1997) (45)
Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry (2008) (45)
R/D optimal linear prediction (2000) (45)
Upper extremity deep vein thrombosis: risk factors, diagnosis, and management. (2001) (43)
Symptomatic deep-vein thrombosis and the post-thrombotic syndrome. (1995) (42)
Healthcare burden associated with the post‐thrombotic syndrome and potential impact of the new oral anticoagulants (2012) (42)
Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients (2008) (42)
Residual vein thrombosis and trans-popliteal reflux in patients with and without the postthrombotic syndrome (2013) (41)
Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry (2010) (41)
Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. (2009) (41)
Treatment of deep venous thrombosis by fixed doses of a low-molecular-weight heparin (CY216). (1990) (40)
Risk stratification of patients with acute symptomatic pulmonary embolism (2016) (40)
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions. (2018) (40)
Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study. (2015) (40)
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. (2013) (39)
The natural history of deep-vein thrombosis. (1997) (39)
Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE registry. (2006) (39)
Cancer and thromboembolic disease: how important is the risk of thrombosis? (2002) (38)
The long‐term risk of cancer in patients with a first episode of venous thromboembolism (2009) (38)
Association between thrombophilia and the post‐thrombotic syndrome: a systematic review and meta‐analysis (2014) (38)
The post-thrombotic syndrome (2000) (38)
Cancer and venous thromboembolism. (2006) (38)
Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism (1999) (38)
Nomograms for the Administration of Unfractionated Heparin in the Initial Treatment of Acute Thromboembolism – an Overview (2000) (37)
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry (2019) (37)
The Utility of Non-invasive Tests for Detection of Previous Proximal-vein Thrombosis (1995) (37)
Is Incidentally Detected Pulmonary Embolism in Cancer Patients Less Severe? A Case-Control Study (2012) (35)
Diagnostic strategies for the management of patients with clinically suspected deep‐vein thrombosis (1997) (35)
Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry (2014) (35)
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update (2012) (34)
Which Is the Outcome of the Post-thrombotic Syndrome? (1999) (33)
Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale. (2020) (33)
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome (2016) (33)
Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. (1999) (33)
Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis (1992) (32)
The pathogenesis of venous thromboembolism. (1995) (31)
Low molecular weight heparins: are they interchangeable? Yes (2003) (31)
Venous and Arterial Thrombosis: Is There a Link? (2015) (31)
Risk Factors of Recurrent Venous Thromboembolism: The Role of Residual Vein Thrombosis (2003) (30)
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE (2020) (30)
A New Computerized Impedance Plethysmograph: Accuracy in the Detection of Proximal Deep-Vein Thrombosis in Symptomatic Outpatients (1991) (29)
A prospective study on survival in cancer patients with and without venous thromboembolism (2013) (29)
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism (2018) (29)
The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months (2010) (29)
Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines (2008) (28)
Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis (1998) (28)
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism (2004) (28)
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients (2019) (27)
MOOC Adventures in Signal Processing: Bringing DSP to the era of massive open online courses (2016) (27)
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. (2017) (27)
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis (2012) (26)
The Value of Ultrasound Screening for Proximal Vein Thrombosis after Total Hip Arthroplasty (2001) (26)
Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry (2018) (26)
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. (2018) (26)
Thrombophilia as a predictor of persistent residual vein thrombosis (2008) (25)
Dabigatran antagonizes growth, cell‐cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines (2016) (25)
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension. (2016) (25)
Optimal segmentation techniques for piecewise stationary signals (1999) (25)
Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score (2016) (25)
Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report. (2006) (24)
Development and Validation of a Practical Two-Step Prediction Model and Clinical Risk Score for Post-Thrombotic Syndrome (2018) (24)
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study. (2015) (24)
The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs. (2011) (23)
Interactive DSP education using Java (1998) (23)
Deep Vein Thrombosis and Fibrinolysis (1991) (23)
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry (2019) (23)
Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age‐related prospective cohort study (2013) (22)
Venous thromboembolism as first manifestation of cancer. (2001) (22)
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism (2017) (22)
Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. (2014) (22)
Postthrombotic syndrome: incidence, prevention, and management. (2001) (22)
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism (2017) (22)
The value of 64-detector row computed tomography for the exclusion of pulmonary embolism (2011) (22)
Optimal duration of anticoagulation (2014) (22)
Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis (2017) (21)
Pregnancy-related Recurrent Events in Thrombophilic Women with Previous Venous Thromboembolism (2001) (21)
Idiopathic venous thromboembolism as a first manifestation of cancer. (2001) (21)
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants (2019) (20)
Controversies in the management of cancer-associated thrombosis (2017) (20)
Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders (2008) (20)
Scoring Systems for Estimating Risk of Venous Thromboembolism in Hospitalized Medical Patients (2017) (20)
Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. (2014) (20)
Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study (2009) (20)
Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry (2018) (19)
Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. (2008) (19)
Timbre Characterization with Mel-Cepstrum and Neural Nets (1994) (19)
Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis (1998) (19)
Thrombophilia and the risk of post‐thrombotic syndrome: retrospective cohort observation (2010) (19)
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. (2014) (19)
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study (2010) (19)
Can causes of false-normal D-dimer test [SimpliRED] results be identified? (2003) (18)
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis (2017) (18)
The G20210A prothrombin gene mutation: is there room for screening families? (2004) (18)
Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis. (2017) (18)
Heparins and Venous Thromboembolism: Current Practice and Future Directions (2001) (18)
Pulmonary embolism: Epidemiology and registries. (2015) (18)
Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark. (2015) (18)
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer (2015) (17)
The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy (2011) (17)
Venous Thromboembolism and Arterial Complications (2012) (17)
D‐dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis (2007) (17)
Inferior Vena Cava Filters (2013) (17)
Recurrent thromboembolism in cancer patients: incidence and risk factors. (2003) (17)
Low rate of venous thromboembolism in asymptomatic relatives of probands with factor V Leiden mutation. (1999) (16)
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review (2018) (16)
Anticoagulants and cancer survival. (2006) (16)
Further evidence in support of the association between venous thrombosis and atherosclerosis: a case-control study. (2014) (16)
Duration of anticoagulation after isolated pulmonary embolism (2016) (16)
Acquired Risk Factors of Venous Thromboembolism in Medical Patients (2006) (16)
Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies (2015) (16)
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg (2008) (15)
Long-term clinical course of proximal deep venous thrombosis and detection of recurrent thrombosis. (2001) (15)
Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism. (2016) (15)
[Occult pulmonary embolism in patients with proximal deep venous thrombosis]. (1991) (15)
Is there a link between venous and arterial thrombosis? A reappraisal (2019) (15)
Clinical and economic impact of compression in the acute phase of deep vein thrombosis (2018) (15)
Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm (2018) (15)
The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin (2020) (15)
How to effectively manage the event of bleeding complications when using anticoagulants (2016) (15)
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study (2005) (15)
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. (2020) (15)
Immobilization resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients (2007) (15)
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab (2017) (15)
Gynecology and Obstetrics (2013) (15)
Fondaparinux in the initial and long-term treatment of venous thromboembolism. (2015) (15)
Prevention of venous thromboembolism in high-risk surgical and medical patients. (2001) (14)
The clinical utility of objective diagnostic tests for diagnosing deep vein thrombosis of the leg. (1989) (14)
A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome (2016) (14)
Systematic Review and Meta-Analysis of Utility of Graduated Compression Stockings in Prevention of Post-Thrombotic Syndrome. (2016) (14)
Venous thromboembolism risk and management in women with cancer and thrombophilia. (2005) (14)
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease (2020) (14)
Risk and prognosis of cancer after upper-extremity deep venous thrombosis: A population-based cohort study. (2018) (14)
Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation (2008) (14)
An international survey on isolated subsegmental pulmonary embolism. (2013) (13)
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease (2016) (13)
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials. (2017) (13)
Light field panorama by a plenoptic camera (2014) (13)
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism. (2015) (13)
Deep-vein thrombosis of the lower limbs: diagnosis and management. (1994) (12)
From Lagrange to Shannon... and back: another look at sampling [DSP Education] (2009) (12)
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts (2020) (12)
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism (2021) (12)
Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders. (2008) (12)
The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations. (2015) (12)
Prevalence and patterns of symptomatic thromboembolism in oncohematology. (1998) (12)
Physicians’ compliance with the Padua Prediction Score for preventing venous thromboembolism among hospitalized medical patients (2013) (12)
Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study (2012) (12)
Deep vein thrombosis of the lower limbs: diagnosis and management. (1994) (11)
Family history of venous thrombosis or sudden death as a risk factor for venous thromboembolism (2012) (11)
From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension. (2005) (11)
Venous thromboembolism and risk of cancer in patients with diabetes mellitus. (2016) (11)
Teaching signal processing online: A report from the trenches (2013) (11)
Perceptually hidden data transmission over audio signals (1998) (11)
The Treatment of Venous Thromboembolism in Patients with Cancer. (2017) (11)
An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study. (2017) (10)
Recurrent venous thromboembolism in men and women. (2004) (10)
Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension (2015) (10)
Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance (1994) (10)
Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis. (2020) (10)
Peripherally inserted catheters: all that glitters is not gold (2013) (10)
Treatment for Patients With Cancer (2013) (10)
Baseline Analysis on the Outcome of Patients with Deep Vein Thrombosis (DVT) Before the Global Impact of New Oral Anticoagulants in Italy: Data from RIETE Registry (2014) (10)
Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis. (2019) (10)
Transaminase Elevation in Patients Treated with Unfractionated Heparin or Low Molecular Weight Heparin for Venous Thromboembolism (1998) (10)
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. (2018) (10)
Cost–effectiveness of bemiparin in the prevention and treatment of venous thromboembolism (2006) (10)
Screening for thrombophilia in children: a puzzling decision with unclear implications (2004) (10)
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE (2021) (10)
[Diagnosis of deep venous thrombosis of the legs: accuracy of ultrasonography using vein compression]. (1990) (9)
Prophylaxis of catheter-related thrombosis in cancer patients (2009) (9)
Bemiparin in Oncology (2010) (9)
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality (2019) (9)
Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it? (2021) (9)
Low Rate of Venous Thromboembolism in Asymptomatic Relatives of Probands with Factor V Leiden Mutation (1999) (9)
Heart disease in patients with pulmonary embolism (2010) (9)
Aspirin and recurrent venous thromboembolism (2013) (9)
The value of thoraco-abdominal CT scanning for the detection of occult cancer in patients with unprovoked venous thromboembolism. A randomized study (2012) (9)
Venous thromboembolism in 2013: The advent of the novel oral anticoagulants (2014) (9)
Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial) (2010) (9)
Thrombosis as a harbinger of cancer (2006) (9)
A Pilot Study of Pro-Urokinase in the Treatment of Deep Vein Thrombosis (1994) (9)
Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study (2012) (9)
Residual vein thrombosis and the risk of subsequent serious complications. (2015) (9)
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention (2021) (8)
Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis (2007) (8)
Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis (1995) (8)
Safety of low molecular weight heparins in the treatment of venous thromboembolism (2003) (8)
Toward the Simplification of Antithrombotic Treatment of Venous Thromboembolism (2004) (8)
Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required? (2020) (8)
Prevention of deep venous thrombosis (1987) (8)
Changing Features of Proximal Vein Thrombosis Over Time (1994) (8)
Sex and anticoagulation in patients with idiopathic venous thromboembolism (2006) (8)
Optimal duration of anticoagulation in patients with venous thromboembolism (2011) (8)
Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma (1990) (8)
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register (2020) (8)
Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies (2015) (8)
Low-Molecular-Weight Heparin versus Compression Stockings for Thromboprophylaxis after Knee Arthroscopy (2008) (8)
Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-LegColor-CodedDopplerUltrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis (2012) (8)
An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia. (2003) (8)
Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism. (2016) (8)
The impact of deep vein thrombosis on the risk of subsequent cardiovascular events: a 14-year follow-up study. (2017) (8)
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities (2009) (8)
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE (2021) (8)
Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia. (2001) (8)
Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis (2021) (8)
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors (2003) (8)
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register (2022) (8)
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study (2019) (7)
Ketorolac suppositories in the treatment of neoplastic pain : a randomized clinical trial versus diclofena (1991) (7)
Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation (2008) (7)
Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy. (2015) (7)
Diagnosis and Anticoagulant Treatment * (2013) (7)
Oral and Poster Presentations (2003) (7)
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study. (2020) (7)
New anticoagulants for the treatment of venous thromboembolism. (2013) (7)
Post-thrombotic syndrome - a position paper from European Society of Vascular Medicine. (2021) (7)
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis (2017) (7)
D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry (2020) (7)
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study (2019) (7)
Aspirin After Oral Anticoagulants for Prevention of Recurrence in Patients with Unprovoked Venous Thromboembolism. the Warfasa STUDY (2011) (7)
Outcome of patients with suspected lower limb symptomatic deep vein thrombosis and a normal ultrasound‐based initial diagnostic workup: a prospective study (2012) (7)
Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials. (2014) (7)
A prospective cohort study on patients treated with anticoagulants for cerebral vein thrombosis (2012) (7)
Failure of soluble fibrin polymers in the diagnosis of clinically suspected deep venous thrombosis. (1999) (7)
Inter-observer variability of compression ultrasound for the assessment of residual vein thrombosis. (2016) (6)
Cancer and Venous Thromboembolism. Clinical Implications of Strong Association (2006) (6)
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE (2021) (6)
What is the role for antithrombotics in cancer care? Interactive session with panel discussion. (2002) (6)
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. (2015) (6)
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism. (2006) (6)
Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux. (2021) (6)
The treatment of venous thromboembolic disorders: new challenges and opportunities. (2003) (6)
Biosimilars of low‐molecular‐weight heparin products: fostering competition or reducing ‘biodiversity’? (2016) (6)
Venous thrombosis and risk of cancer in patients with arterial cardiovascular disease. (2015) (6)
[Venous thromboembolism and neoplasms]. (2000) (6)
Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood. (1985) (6)
Venous Thromboembolism and Port-Related Thrombosis in Metastatic Colorectal Cancer Patients: A Monocenter Experience (2010) (6)
Low Rate of Warfarin-related Major Bleeding in Patients with Recurrent Venous Thromboembolism (1999) (6)
Relevance of Inherited Risk Factors in Young Patients with Deep-Vein Thrombosis (1996) (6)
Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study (2018) (6)
Deep vein thrombosis and occult cancer. (1993) (6)
Medical patients. (2013) (6)
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years (2019) (6)
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. (2021) (6)
Diagnosis of recurrent deep vein thrombosis. (2001) (5)
External validation of the simplified Geneva risk assessment model for hospital‐associated venous thromboembolism in the Padua cohort (2019) (5)
Non-Intrusive Speech Quality Assessment with Transfer Learning and Subject-Specific Scaling (2021) (5)
Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism (2005) (5)
Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. (2018) (5)
Approach to Venous Thromboembolism in the Cancer Patient (2011) (5)
Prevention and treatment of the chronic thromboembolic pulmonary hypertension. (2018) (5)
Below-knee elastic compression stockings for prevention of the post-thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study (2003) (5)
Optimal bit allocation with side information (1999) (5)
More on: vitamin K antagonists and cancer (2008) (5)
Combined inherited protein S and heparin co-factor II deficiency in a patient with upper limb thrombosis: a family study. (1992) (5)
More on: venous thromboembolism and mortality after hip fracture: the ESCORTE study (2006) (5)
The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study (2021) (5)
Recurrence of venous thromboembolism and its prevention (2008) (5)
Enhanced “In Vitro“ Release of Platelet α-Granules After Acute Myocardial Infarction (AMI) (1985) (5)
CLINICAL PREDICTION OF vTE RECURRENCE IN PATIENTS WITH PREvIOUS UNPROvOKED vENOUS THROMBOEMBOLISM. RESULTS FROM AN INDIvIDUAL-LEvEL META-ANALYSIS (2015) (4)
Usefulness of CHA2DS2-VASc Score to Predict Stroke Risk Independent of Atrial Fibrillation. (2019) (4)
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism (2021) (4)
Clinical characteristics of italian patients with venous thromboembolism enrolled in the RIETE Registry (2011) (4)
COMPUTERIZED IMPEDANCE PLETHYSMOGRAPHY, A NEW PLETHYSMOGRAPHIC METHOD TO DETECT DEEP VEIN THROMBOSIS (1987) (4)
Health‐care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN‐CHOICE Trial Population (2018) (4)
Influence of Body Mass Index on Clinical Outcomes in Venous Thromboembolism: Insights from GARFIELD-VTE. (2021) (4)
[Profiles of medical malpractice in the prophylaxis of pulmonary thromboembolism]. (2003) (4)
The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough? (2012) (4)
Sensorcam: an energy-efficient smart wireless camera for environmental monitoring (2012) (4)
The treatment of venous thromboembolism in patients with cancer (2010) (4)
Fondaparinux Reduces All Types of Symptomatic Thromboembolic Complications in Patients with Superficial-Vein Thrombosis in the Legs: Data From the CALISTO Study (2011) (4)
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. (2018) (4)
Management of thrombosis in patients with hematologic malignancies. (2002) (4)
What are the pharmacotherapy options for treating venous thromboembolism in cancer patients? (2014) (4)
SEGMENTATION FOR SIGNAL MODELING AND COMPRESSION (1997) (4)
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study (2007) (3)
Confirmation of the Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis (1991) (3)
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism (2020) (3)
Thromboprophylaxis in medical inpatients with cancer. (2014) (3)
Home treatment and secondary prevention of deep vein thrombosis. (2001) (3)
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study (2021) (3)
Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants. (2016) (3)
Postthrombotic syndrome. (2006) (3)
Risk of Cancer in Patients Presenting with Venous Thromboembolism (2004) (3)
Should cancer patients receive thromboprophylaxis to prevent catheter-related upper limb deep vein thrombosis? (2008) (3)
Controversial Issues in the Diagnosis of Venous Thromboembolism (2003) (3)
Venous thromboembolism and subsequent diagnosis of subarachnoid hemorrhage: a 20‐year cohort study (2010) (3)
The optimal treatment of venous thrombosis: current status and future perspectives. (2001) (3)
Incidence of Arterial Embolism in Patients on Treatment with Old and New Anticoagulants for Venous Thromboembolism (2015) (3)
Long-term sequelae of deep-vein thrombosis (1990) (3)
[Treatment of venous thromboembolic disease using low molecular weight CY216 heparin in patients with high risk of hemorrhage]. (1988) (3)
Predicting venous thromboembolism in hospitalized medical patients: are we there yet? (2011) (3)
Pregnancy-related venous thromboembolism and risk of occult cancer. (2017) (3)
R/D optimal data hiding (1999) (3)
Anticoagulant Treatment in Patients with Cancer and Venous Thrombosis Recurrent Venous Thromboembolism and Bleeding Complications During (2013) (3)
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin (2021) (3)
The treatment of cancer-associated venous thromboembolism in the era of the novel oral anticoagulants (2015) (3)
A family with an abnormal protein C and a thrombotic tendency. (1993) (3)
VITRAIL: Acquisition, Modeling, and Rendering of Stained Glass (2016) (3)
New developments in noninvasive diagnosis of deep vein thrombosis of the lower limbs (1990) (3)
Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism (2018) (3)
Lessons learned from cancer/VTE Registries: report from RIETE. (2007) (3)
Cost-Effectiveness of Prevention and Treatment of VTE (2013) (3)
Poster abstract: Sensorcam: An energy-efficient smart wireless camera for environmental monitoring (2012) (2)
Low-molecular-weight heparin and the survival of patients with advanced malignancy. (2004) (2)
21th European Congress on Obesity (ECO2014), Sofia, Bulgaria, May 28-31, 2014: Abstracts (2014) (2)
[Therapeutic indications for acute venous thromboembolism. Current status and future perspectives]. (2003) (2)
Vaginal bleeding in early pregnancy and risk of occult cancer (2019) (2)
[Unreliability of the clinical diagnosis of deep venous thrombosis of the legs. A prospective study]. (1988) (2)
Isolated Iliac Vein Thrombosis During Oral Contraceptive Therapy in Three "Normal" Women (1997) (2)
General, Vascular, Bariatric, and Plastic Surgical Patients (2013) (2)
Treatment of venous thromboembolism: the single-drug approach. (2013) (2)
A combination of dipyridamole with low-dose aspirin in the treatment of unstable angina. A multicenter pilot study (1990) (2)
Do malfunctioning bioprosthetic heart valves represent a potential thrombogenic focus? (1985) (2)
Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism (1998) (2)
Surgical thrombectomy. (2013) (2)
New strategies for the treatment of acute venous thromboembolism. (2006) (2)
Risk of subsequent malignant neoplasms in patients with deep-vein thrombosis (1990) (2)
A mixed-framework arithmetic coder (1997) (2)
Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE (2020) (2)
Determinants of severe post-thrombotic syndrome: The role of thrombus location. (2019) (2)
[Treatment of unstable angina with dipyridamole combined with low doses of aspirin. A multicenter pilot double-blind controlled study]. (1991) (2)
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study (2022) (2)
Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism. (2006) (2)
Prevention of thromboembolic complications in patients with atrial fibrillation. (2008) (2)
Vitamin K antagonists and cancer: reply to rebuttal (2004) (2)
Failure of Thrombin-Antithrombin III Complexes in the Diagnosis of Deep Vein Thrombosis (1992) (2)
The optimal long-term treatment of venous thromboembolism. (2004) (2)
High rate of inter-observer agreement between professional-rated scores of the Villalta scale for the assessment of the post-thrombotic syndrome. (2016) (2)
Emerging strategies for treatment of venous thromboembolism (2005) (2)
[Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan]. (1989) (2)
Residual venous thrombosis and recurrent thromboembolism. Authors' reply (2003) (2)
Low reproducibility of the diagnosis of subsegmental pulmonary embolism in symptomatic patients. (2019) (2)
Combined Modalities in Surgical Patients (2013) (2)
[The side effects of phlebography of the lower extremities using iohexol. A prospective study]. (1989) (1)
Recent venous thromboembolism amongst adult individuals attending general practitioner ambulatory (the FAST study): prevalence of cardiovascular risk factors. (2008) (1)
Abstracts of the 25th Biennial International Congress on Thrombosis (2018) (1)
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism. (2016) (1)
Pulmonary Embolism in Patients Hospitalized for Syncope. (2017) (1)
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review. (2022) (1)
Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study. (2023) (1)
New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery (2011) (1)
LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY (2007) (1)
The Problem and the Need for Prevention (2013) (1)
Key Questions to be Answered (2013) (1)
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial (2022) (1)
[Hepatic injury in mitral valvular cardiopathy. Clinical and diagnostic aspects]. (1987) (1)
Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders (2022) (1)
Venous Thromboembolism and Cancer (2007) (1)
Bleeding after low-molecular-weight heparin (1992) (1)
The value of inhibitors of factor Xa for the treatment of pulmonary embolism (2014) (1)
[Acute endocarditis caused by Staphylococcus aureus in a drug addict]. (1982) (1)
Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis (2021) (1)
[Diagnosis of deep vein thrombosis in ambulatory patients: echo-doppler and d-dimer]. (1998) (1)
Diagnosing Cancer in Patients with Venous Thromboembolism (2007) (1)
Deep-vein thrombosis and the incidence of subsequent malignant disease (1992) (1)
Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register (2022) (1)
Risk Factors for Venous Ulcer Following ACUTE Venous Thromboembolism: Results from the Riete Registry (2015) (1)
Information Theory in Modem Practice (1997) (1)
The incidence of venous thromboembolism in asymptomatic carriers of antithrombin, protein C or protein S: a prospective cohort study. (1999) (1)
[Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study]. (1986) (1)
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study (2019) (1)
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism (2021) (1)
[Non-bacterial thrombotic endocarditis and hypercoagulability in mucinous adenocarcinoma. Description of a case]. (1984) (1)
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective multicenter, cohort study: reply to a rebuttal (2009) (1)
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry (2020) (1)
The Natural History of Venous Thromboembolism (2009) (1)
Critical Care Medical Patients (2013) (1)
Venous thrombotic burden and the risk of subsequent overt cancer (2015) (1)
Teaching Practical DSP with Off-the-shelf Hardware and Free Software (2019) (1)
Thrombolytic Therapy (2013) (1)
Weight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis. (2021) (1)
Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. (2019) (1)
Light transport matrix recovery for nearly planar objects (2014) (1)
Effectiveness of fixed-dose low-molecular-weight heparin (CY216) compared with adjusted-dose standard heparin in the treatment of proximal-vein thrombosis (1992) (1)
Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised? (2020) (1)
[Unreliability of clinical diagnosis of deep venous thrombosis of the lower extremities]. (1987) (1)
[Diagnostic aspects and results of drug therapy in pulmonary thromboembolism]. (1985) (1)
Residual Clot in Patients with Deep Vein Thrombosis and Pulmonary Embolism: Prognostic Implications Keywords: Deep vein thrombosis; Pulmonary embolism; (2015) (1)
Trans-popliteal reflux in limbs with and without deep-vein thrombosis of the same subject: Cross-sectional study. (2017) (1)
Orthopedic Surgery and Trauma (2013) (1)
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry (2022) (0)
Other Uses of LMWHs – Miscellaneous (1998) (0)
Association Between Inherited and Acquired Thrombophilias and The Post Thrombotic Syndrome: A Systematic Review and Metaanalysis (2013) (0)
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry. (2023) (0)
Iliofemoral deep vein thrombosis should not be managed routinely with thrombolysis and stenting. (2022) (0)
Th-P15:45 Increased levels of small, dense, oxidized LDL in patients with idiopathic venous thromboembolism: A common link with atherosclerosis (2006) (0)
A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism (2020) (0)
[Pulmonary thromboembolism in the elderly]. (1987) (0)
Threatened abortion and risk of cancer (2018) (0)
Which is the outcome of the post-thrombotic syndrome? (1999) (0)
[Has high-definition spiral computed tomography changed the management of patients with acute pulmonary embolism?]. (2008) (0)
Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study (2013) (0)
C0025: The Impact of Residual Thrombosis on the Outcome of Patients with Deep-Vein Thrombosis (2014) (0)
Effect of patient's sex on risk of recurrent venous thromboembolism : a meta-analysis. Commentary (2007) (0)
LOW MOLECULAR-WEIGHT HEPARIN CY216 IN THE TREATMENT OF ACUTE MASSIVE PULMONARY EMBOLISM (1987) (0)
BETA-THR~I0BULIN ('s -'IIS) AND PIA'TELET FAcMlR 4 (PF4) RELEASE BY ADENOSINE DIPHOSPHATE (ADP) CONTACTWITHNATIVEWHOLE = (1985) (0)
Healthcare Cost Impact of Continued Anticoagulation with Rivaroxaban versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the EINSTEIN-CHOICE Trial Population Continued Anticoagulation with Rivaroxaban for Prevention of Recurrent Symptomatic Venous Thromboembolism in (2018) (0)
The role of impedance plethysmography in suspected pulmonary embolism (1990) (0)
[Cardiac valve prostheses and pregnancy]. (1981) (0)
[Effect of dipyridamole in the prevention of aortic arteriosclerosis caused by hypercholesterolic diet in rabbits]. (1982) (0)
LBA48ORAL RIVAROXABAN VERSUS STANDARD THERAPY FOR THE TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER (2014) (0)
Ximelagatran reduced venous thromboembolism more than warfarin after total knee replacement (2004) (0)
SIDE EFFECTS OF ASCENDING VENOGRAPHY (1987) (0)
Prevention of Postthrombotic Syndrome (2013) (0)
population-based study Long-term use of vitamin K antagonists and incidence of cancer: a (2011) (0)
Analysis and Design of Large-scale Online Classes (2014) (0)
[Thrombolytic therapy with urokinase in 8 patients with massive pulmonary thromboembolism]. (1985) (0)
Interpolation and Sampling (2008) (0)
Antiphospholipid Antibodies Do Not Seem to Be Associated With Deep Vein Thrombosis: A Case Control Study (1997) (0)
Paper1-03 jan 1998 (1997) (0)
Venous Thromboembolism and Malignant Diseases (2006) (0)
“Thrombotic aura”: a case report (2012) (0)
The Z-Transform (2008) (0)
A/D and D/A Conversions (2008) (0)
How I treat How I treat venous thromboembolism in patients with cancer (2005) (0)
Risk Factors and Prevention of VenousThromboembolism in Ambulatory Cancer PatientsRequiring Chemotherapy (2019) (0)
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history (2022) (0)
Practice Guidelines Chest Physicians Evidence-Based Clinical Thrombosis, 9th ed: American College of Antithrombotic Therapy and Prevention of Antithrombotic Therapy for VTE Disease : (2012) (0)
Digital Signal Processing (2008) (0)
Atherosclerosis as a potential risk factor of venous thrombosis (2003) (0)
Sonological models for timbre characterizationGiovanni (1997) (0)
Early liver transplantation in active drinkers with and without alcoholic hepatitis: a monocentric case series (2020) (0)
An unusual finding of massive pulmonary embolism in a patient during treatment with high-dose ibuprofen (2016) (0)
A PROSPECTIVE ALGORITHM INCORPORATING LIMITED AND WHOLE-LEG ASSESSMENT OF THE DEEP VENOUS SYSTEM IN SYMPTOMATIC OUTPATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (THE PALLADIO STUDY) (2016) (0)
C0119: Subsequent Arterial Events in Patients with Acute Venous Thromboembolism. Findings from the Riete Registry (2014) (0)
On the True Prevalence of Pulmonary Embolism in Patients Hospitalized for a First Syncopal Event. (2019) (0)
O9 Fondaparinux 2.5 mg for the treatment of symptomatic, isolated superficial thrombophlebitis (ST): preliminary baseline data from the randomized placebo-controlled CALISTO trial (2009) (0)
Association between venous and arterial thrombosis – Authors' reply (2008) (0)
are carriers of factor V Leiden: a prospective cohort study Incidence of venous thromboembolism in asymptomatic family members who (2013) (0)
No difference in outcome between therapeutic and preventive anticoagulation in patients with superficial vein thrombosis involving the saphenous–femoral junction (2022) (0)
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review. (2022) (0)
Risk Factors and Prevention of Venous Thromboembolism in Ambulatory Cancer Patients Requiring Chemotherapy (2019) (0)
Cancer Screening in Unprovoked Venous Thromboembolism. (2015) (0)
Adherence to the novel oral anticoagulants: an unmet need (2015) (0)
Regular Article Can causes of false-normal D-dimer test (SimpliREDR) results be identified? (2003) (0)
Mo-P1:127 Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis (2006) (0)
Stochastic Signal Processing (2008) (0)
Study Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a (2013) (0)
Thromboprophylaxis in Pregnancy, Orthopaedic Surgery Patients and in Long-Term Strategies (1998) (0)
Current status of the clinical use of heparin fractions (1989) (0)
Thromboprophylaxis in Pregnancy, Orthopaedic Surgery Patients and in Long-Term Strategies (1998) (0)
Home Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparins (1998) (0)
Ximelagatran prevented secondary venous thromboembolism (2004) (0)
Italian Journal of Prevention, Diagnostic and Therapeutic Medicine (2020) (0)
The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study (2003) (0)
Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry. (2022) (0)
proximal-venous thrombosis : a randomized trial prevention of the postthrombotic syndrome in patients with Thigh-length versus below-knee compression elastic stockings for (2012) (0)
Fragile patients with venous thromboembolism. What did we learn from RIETE. (2015) (0)
Stroboscopy automatic video-sequence. (2001) (0)
[Aplastic anemia and pregnancy: description of a case]. (1982) (0)
Subject Index, Vol. 20, 1990 (1990) (0)
Risk Factors Common to Arterial and Venous Thrombosis (2012) (0)
[Massive pulmonary thromboembolism. Thrombolytic therapy with urokinase: proposed common protocol]. (1980) (0)
PO-58 Low-molecular weight heparin antagonizes the CXCL12-driven migration of chronic lymphocytic leukemia B cells (2007) (0)
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study (2022) (0)
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. (2003) (0)
Clinical course of deep venous thrombosis [7] (multiple letters) (1997) (0)
Author Index / Subject Index, Vol. 25, 1995 (1995) (0)
MF 701 Dermatan sulphate for prevention of deep vein thrombosis (DVT) after general surgery (1990) (0)
[ST-segment trend in patients with acute myocardial infarction treated with antithrombotic drugs (author's transl)]. (1981) (0)
Air travel and thromboembolism (2001) (0)
Design of a Digital Communication System (2008) (0)
Long-term strategies in patients with unprovoked venous thromboembolism (2017) (0)
Tromboembolismo venoso e neoplasia [Venous thromboembolism and neoplasms]. (2000) (0)
Incidence of cancer in the follow-up of patients with idiopathic and secondary VTE Frequency of cancer Idiopathic VTE Secondary VTE (1997) (0)
[Whole liver in secondary anemia]. (1952) (0)
[Thrombotic thrombocytopenic purpura]. (1987) (0)
A prospective algorithm incorporating limited and whole- leg assessment of the deep venous system in symptomatic outpatients (the Palladio study) (2015) (0)
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study (2022) (0)
Clinical Course of Deep Venous Thrombosis (1997) (0)
CIRCULATING MICROPARTICLES AND HYPERCOAGULABILITY IN OBESITY (2018) (0)
Other Uses of LMWHs – Miscellaneous (1998) (0)
Retinal vein thrombosis and risk of cancer: A population-based cohort study (2018) (0)
Long-term use of vitamin K antagonists in patients with atrial fibrillation and cancer incidence: a pharmaco-epidemiological study (2013) (0)
Discrete-Time Signals (2008) (0)
[Clinical and instrumental aspects of the liver caused by stasis in patients with heart valve diseases. Considerations on 15 patients, 7 of whom were treated with valve prostheses]. (1981) (0)
Urologic Surgery (2013) (0)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. (2022) (0)
Multirate Signal Processing (2008) (0)
Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis? (2017) (0)
COMPRESSION ULTRASONOGRAPHY FOR DIAGNOSTIC MANAGEMENT OF PATIENTS WITH CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS : PROSPECTIVE COHORT STUDY (1998) (0)
The management of superficial and deep venous thrombosis in patients with cancer (2007) (0)
Contents Vol. 33 (2003) (0)
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results (2022) (0)
Residual Venous Thrombosis and Recurrent Thromboembolism (2003) (0)
Pharmacokinetics of ketorolac tromethamine following oral and rectal administration (1990) (0)
State-of-the-Art Review : Prevention of Venous Thromboembolism in Major Orthopedic Surgery (1996) (0)
Systemic or Venous Thromboembolism Global Anticoagulant Registry in the Field – Venous Thromboembolism ( GARFIELD-VTE ) Rationale and design (2016) (0)
Prevention of recurrent VTE in patients with unprovoked VTE (2013) (0)
Aspirin but not ticlopidine inhibits PAI-1 antigen release by human platelets (1990) (0)
Strategies: A Scientific Statement From the American Heart Association The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment (2014) (0)
Fondaparinux 2.5mg for the Treatment of Symptomatic, Isolated Superficial Vein Thrombosis (SVT): Preliminary Data From the Randomized Placebo-Controlled CALISTO Trial (on Behalf of the CALISTO Investigators). (2009) (0)
Author and Subject Index (2001) (0)
9 The Post Thrombotic Syndrome (2017) (0)
Obituary JW ten Cate. (2021) (0)
Below-knee stockings reduce post-thrombotic syndrome in patients with proximal deep vein thrombosis (2004) (0)
Corrigendum to “Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE” [Thromb. Res. 2020 Jul; 191:103–112] (2021) (0)
Fixed doses of a low-molecular weight heparin (CY 216) in the treatment of deep-vein thrombosis (1990) (0)
Signals and Hilbert Spaces (2008) (0)
The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry. (2022) (0)
Title Page / Table of Contents, Vol. 20, Supplement 1, 1990 (1990) (0)
Deep-vein thrombosis. (1999) (0)
New perspectives for prevention of the post-thrombotic syndrome (2022) (0)
[Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin]. (1984) (0)
[Diagnosis of deep venous thrombosis of the lower limbs]. (1988) (0)
Acquired risk factors for unexplained venous thrombosis (1992) (0)
On the questionable ethics of randomizing patients with acute DVT to receive rivaroxaban or warfarin. (2020) (0)
Guessing the fingerings from musical recordings (2012) (0)
CLINICAL COURSE OF DEEP VENOUS THROMBOSIS. AUTHORS' REPLY (1997) (0)
Fragile Patients With Venous (2015) (0)
C0026: The Value of CT Scanning for the Detection of Occult Cancer in Patients with Unprovoked Thromboembolism (2014) (0)
C0089: Unexpectedly High Recanalization Rate in Patients with Pulmonary Embolism Treated with Anticoagulants Alone (2014) (0)
Discrete-Time Filters (2008) (0)
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism. (2016) (0)
Reverse Digital Typography (2012) (0)
Thrombin-antithrombin complexes in the diagnosis of deep-vein thrombosis (1990) (0)
LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) - BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS (2007) (0)
The hazard of therapeutic doses of anticoagulants in patients with isolated subsegmental pulmonary embolism. (2023) (0)
Variables Influencing Outcome in Cancer Patients with Venous Thromboembolism: Data from the RIETE Registry (2009) (0)
Cotton vs nylon compression elastic stockings comparison of tolerability (1990) (0)
The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation? (2011) (0)
Iliopsoas bursitis and femoral vein thrombosis complicating total hip arthroplasty in an elderly patient (2017) (0)
Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary (2015) (0)
Challenges in the diagnosis of sub-segmental pulmonary embolism in symptomatic patients: a case report (2018) (0)
International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients (2012) (0)
[Thrombosis of the renal vein in nephrotic syndrome: clinico-diagnostic and therapeutic aspects]. (1989) (0)
INVITED NARRATIVE REVIEW DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF DEEP VEIN THROMBOSIS: FROM THE MID ’80 TO THE PRESENT DAY (by Paolo Prandoni) Diagnosis of deep vein thrombosis (2022) (0)
A survey on the views and attitudes of Italian physicians with regards to venous thromboembolism prophylaxis and treatment. (2019) (0)
Risk Factors and Coagulation Disorders – LMWH Pharmacokinetics and Pharmacodynamics (1998) (0)
R/d Optimal Linear Prediction Edics: 1-codi (2000) (0)
Ultrasonography to Guide Duration of Anticoagulation in DVT (2009) (0)
[Renal blood flow in hepatic cirrhosis determined by the Xe 133 washout method]. (1976) (0)
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease (2022) (0)
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study (2016) (0)
[Chronic constrictive pericarditis: considerations on 27 cases]. (1980) (0)
extension: lessons from the CALISTO study Clinical relevance of symptomatic superficial-vein thrombosis (2013) (0)
P0710 : Role of hepatitis C virus (HCV) in the early arteriosclerotic process and autonomic disfunction (2015) (0)
LOW MOLECULAR WEIGHT HEPARINS (2018) (0)
Risk Factors and Coagulation Disorders – LMWH Pharmacokinetics and Pharmacodynamics (1998) (0)
Poster discussionLaser nephelometric evaluation of protein C (1990) (0)
Failure of old and new anticoagulants to prevent ischemic stroke in high-risk atrial fibrillation: a case report. (2016) (0)
Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis – RIDTS Study (2021) (0)
The risk of recurrent venous thromboembolism in patients with Arg506->G1n mutation in the gene for factor V (factor V Leiden) Simioni, (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paolo Prandoni?

Paolo Prandoni is affiliated with the following schools:

Paolo Prandoni's Academic­Influence.com Rankings

Why Is Paolo Prandoni Influential?

Paolo Prandoni's Published Works

Published Works

What Schools Are Affiliated With Paolo Prandoni?

Paolo Prandoni's AcademicInfluence.com Rankings